The clinical application of tirzepatide as a treatment for T2D has the potential to provide new insights into the disease and help unravel the role of GIP in its development
Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions
FAMMM syndrome kindreds should have a full skin examination at age 10 and every 6 months thereafter
Thus, the researchers also suggested that the peptide may potentially promote endothelial cell entry into active proliferative states
Our findings align with the previous meta-analysis done by Avogaro et al., which specifies improvement in NT-ProBNP level by GLP-1RA drugs.20 Also, our findings strengthen the findings in secondary analysis of STEP-HFpEF and STEP-HFpEF DM trials by Petrie et al., where they concluded similar improvements.21 The KCCQ-CSS score assesses patients health perceptions, encompassing physical restrictions, symptoms, social limitations, and quality of life, and is crucial for HFpEF patients.22 A change of 5 points is considered clinically meaningful.23 Our meta-analysis found that GLP-1RA therapy considerably improves quality of life, as shown by higher KCCQ-CSS scores
